ESR1 and breast cancer: Luminal B sub-type also has lower expression of several luminal-related genes (such as ESR1 or FOXA1), genomic instability and a higher frequency of TP53 gene mutations associated with a worse prognosis and a higher risk of relapse than luminal A breast cancers [4–6].